Recent Events & Catalysts

Biomarker Collaboration and Licensing Deals Report 2016-2026 - Featuring Quanterix, Caris Life Sciences, Alnylam Pharmaceuticals, Guardant Health, Eurofins Scientific and More

Yahoo · today

Alnylam Pharmaceuticals (NASDAQ:ALNY): A Value Stock Priced Below Biotech Peers with Strong Growth

ChartMill · 4d ago

Collect 9.8% On VRTX Stock Now, And Still Keep 15% Of Upside

Yahoo · 5d ago

Alnylam to Webcast Conference Call Discussing Second Quarter 2026 Financial Results

Yahoo · 5d ago

Alnylam Pharmaceuticals: Commercial Momentum Outweighs TTR Read-Through Concerns

SeekingAlpha · 5d ago

AstraZeneca's Oncology Engine Keeps Running Despite Wainua Setback

SeekingAlpha · 6d ago

Alnylam Highlights Progress with Neuroscience Programs at AAIC 2026, Showcasing Potential of RNAi in Neurological Disease

Yahoo · 6d ago

Alnylam Highlights Neuroscience Progress At AAIC 2026, Initiating Phase 2 APPlauDS Study Of Mivelsiran In Down Syndrome-Associated Alzheimer's While Completing cAPPricorn-1 Enrollment In CAA

Benzinga · 6d ago

Departure/appointment of directors or officers, Submission of matters to a vote of security holders

Filed 2026-05-27 · 55d ago

Results of operations (earnings release), Financial statements and exhibits

Filed 2026-04-30 · 82d ago · Material